PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Misra, S.* ; Wagner, R.* ; Ozkan, B.* ; Schön, M.* ; Sevilla-Gonzalez, M.* ; Prystupa, K.* ; Wang, C.C.* ; Kreienkamp, R.J.* ; Cromer, S.J.* ; Rooney, M.R.* ; Duan, D.* ; Thuesen, A.C.B.* ; Wallace, A.S.* ; Leong, A.* ; Deutsch, A.J.* ; Andersen, M.K.* ; Billings, L.K.* ; Eckel, R.H.* ; Sheu, W.H.* ; Hansen, T.* ; Stefan, N. ; Goodarzi, M.O.* ; Ray, D.* ; Selvin, E.* ; Florez, J.C.* ; Meigs, J.B.* ; Udler, M.S.*

Precision subclassification of type 2 diabetes: A systematic review.

Commun. Med. 3:138 (2023)
Verlagsversion DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
BACKGROUND: Heterogeneity in type 2 diabetes presentation and progression suggests that precision medicine interventions could improve clinical outcomes. We undertook a systematic review to determine whether strategies to subclassify type 2 diabetes were associated with high quality evidence, reproducible results and improved outcomes for patients. METHODS: We searched PubMed and Embase for publications that used 'simple subclassification' approaches using simple categorisation of clinical characteristics, or 'complex subclassification' approaches which used machine learning or 'omics approaches in people with established type 2 diabetes. We excluded other diabetes subtypes and those predicting incident type 2 diabetes. We assessed quality, reproducibility and clinical relevance of extracted full-text articles and qualitatively synthesised a summary of subclassification approaches. RESULTS: Here we show data from 51 studies that demonstrate many simple stratification approaches, but none have been replicated and many are not associated with meaningful clinical outcomes. Complex stratification was reviewed in 62 studies and produced reproducible subtypes of type 2 diabetes that are associated with outcomes. Both approaches require a higher grade of evidence but support the premise that type 2 diabetes can be subclassified into clinically meaningful subtypes. CONCLUSION: Critical next steps toward clinical implementation are to test whether subtypes exist in more diverse ancestries and whether tailoring interventions to subtypes will improve outcomes.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Altmetric
0.000
0.000
1
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Hypertriglyceridemic Waist Phenotype; Insulin-resistance; Cardiovascular-disease; Cluster-analysis; Glycemic Control; Risk; Subgroups; Mellitus; Onset; Association
Sprache englisch
Veröffentlichungsjahr 2023
HGF-Berichtsjahr 2023
ISSN (print) / ISBN 2730-664X
e-ISSN 2730-664X
Zeitschrift Communications Medicine
Quellenangaben Band: 3, Heft: 1, Seiten: , Artikelnummer: 138 Supplement: ,
Verlag Springer
Verlagsort Campus, 4 Crinan St, London, N1 9xw, England
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Diabetes Research and Metabolic Diseases (IDM)
POF Topic(s) 90000 - German Center for Diabetes Research
Forschungsfeld(er) Helmholtz Diabetes Center
PSP-Element(e) G-502400-001
Förderungen NIHR Biomedical Research Centre Funding Scheme
American Heart Association
American Diabetes Association
NIH
Wellcome Trust Career Development scheme
Pediatric Endocrine Society Rising Star Award
Novo Nordisk Foundation
NIH/NHLBI
Doris Duke Foundation
NIH/NIDDK
MOST, Taiwan
Eris M. Field Chair in Diabetes Research
Lund University (Sweden)
Novo Nordisk Foundation (Hellerup, Denmark)
NIGMS
DOI 10.1038/s43856-023-00360-3
WOS ID 001162595300001
PubMed ID 37798471
Erfassungsdatum 2023-11-28
[➜Korrektur melden]